Advertisement
Document › Details
Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona.
Region | North Carolina (federal state) | |
Country | United States (USA) | |
Organisation | Grifols S.A. | |
Group | Grifols (Group) | |
Organisation 2 | FDA (US Food and Drug Administration) | |
Group | United States (govt) | |
Product | Procleix® blood screening system | |
Product 2 | Xembify® (20% sc immunoglobulin) | |
Original document
accessed by [iito] on 2019-07-31
Record changed: 2023-06-05 |
Advertisement
More documents for Grifols (Group)
- [1] Biotest AG. (10/29/24). "Press Release: Biotest and SteinCares Partner to Improve Access to Plasma-derived Products in Latin America". Dreieich....
- [2] Grifols S.A.. (7/4/24). "Press Release: Grifols Appoints Rahul Srinivasan as New Chief Financial Officer". Barcelona....
- [3] Grifols S.A.. (9/7/20). "Press Release: Grifols to Acquire Alkahest to Enhance Discovery Research and Development". Barcelona & San Carlos, CA....
- [4] Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona....
- [5] Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top